Gergana M.
- Country
- Bulgaria
- Department
- N/A
Research Overview
- Efficacy and Safety of MET097 in Adults with Overweight or Obesity: A Phase 3, Randomized, Placebo-Controlled Trial
- Phase 3 Randomized, Placebo‑Controlled Trial Assessing Efficacy and Safety of MET097, a Long‑Acting GLP‑1 Receptor Agonist, in Overweight/Obese Adults with Type 2 Diabetes
- Long-Term Extension Study of Imeroprubart in Adult Patients With Graves' Disease
Data & Insights
Has run more than one trial at 204 of 513 partner sites.
Specializations
Gastroenterology and Functional Constipation
Gergana Marinova is involved in clinical research focused on functional constipation in pediatric populations, including early childhood and very young infants. This area centers on improving symptom control and long-term management options for children with chronic bowel dysfunction.
- Functional constipation
- Pediatric gastroenterology
- Childhood bowel motility disorders
Her work in this field reflects an interest in therapies designed for age-specific gastrointestinal needs and in expanding treatment options for children with persistent constipation.
Cardiovascular Medicine and Thromboembolic Risk
Her clinical trial activity includes studies in atrial fibrillation, stroke prevention, and broader atherosclerotic cardiovascular disease. This research landscape also extends to patients at elevated risk of systemic embolism and major cardiovascular events.
- Atrial fibrillation
- Stroke prevention
- Atherosclerotic cardiovascular disease
The therapeutic focus includes rhythm-related cardiovascular disorders and interventions aimed at reducing embolic and ischemic complications.
Endocrinology, Metabolic Disease, and Weight Management
Gergana Marinova is active in trials addressing type 2 diabetes, obesity, and hyperlipidemia, with additional interest in therapies that support glycaemic control and metabolic risk reduction. Her research also includes cardiovascular-metabolic overlap, particularly in individuals with elevated cardiometabolic risk.
- Type 2 diabetes
- Obesity
- Hyperlipidemia
This area covers treatments directed at blood sugar regulation, body weight reduction, and lipid management.
Pulmonology and Chronic Obstructive Pulmonary Disease
Her research portfolio includes moderate to severe chronic obstructive pulmonary disease, with attention to therapies that may improve lung function and respiratory symptom burden. This reflects involvement in chronic airway disease management and inhaled treatment strategies.
- Chronic obstructive pulmonary disease
- Lung function
- Respiratory disease treatment
The therapeutic emphasis lies in respiratory care for patients with persistent airflow limitation and chronic pulmonary impairment.
Autoimmune and Endocrine Disorders
Gergana Marinova is also involved in clinical studies of Sjögren’s disease and Graves’ disease, indicating interest in autoimmune conditions affecting glandular and thyroid function. Her research activity includes therapies aimed at controlling immune-mediated disease activity and restoring endocrine balance.
- Sjögren’s disease
- Graves’ disease
- Thyroid autoimmunity
This domain includes treatment approaches for systemic autoimmunity and thyroid dysfunction associated with immune dysregulation.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.